Evidence map›Paper›PMID 26805817›Full record

ReviewInternational journal of molecular sciences2016

The Clinical Significance of Phosphorylated Heat Shock Protein 27 (HSPB1) in Pancreatic Cancer.

Mitsuru Okuno, Seiji Adachi, Osamu Kozawa, Masahito Shimizu, Ichiro Yasuda

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. The Critical Role of Ferroptosis in Hepatocellular Carcinoma.Frontiers in cell and developmental biology · 2022
    Review
  10. Roles of ferroptosis in urologic malignancies.Cancer cell international · 2021
    Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Mitsuru OkunoDepartment of Gastroenterology, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu 501-1194, Japan. mkobdkl@yahoo.co.jp.
Seiji AdachiDepartment of Gastroenterology, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu 501-1194, Japan. seijiadachi0123@gmail.com.
Osamu KozawaDepartment of Pharmacology, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu 501-1194, Japan. okozawa@gifu-u.ac.jp.
Masahito ShimizuDepartment of Gastroenterology, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu 501-1194, Japan. shimim-gif@umin.ac.jp.
Ichiro YasudaDepartment of Gastroenterology, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu 501-1194, Japan. yasudaich@gmail.com.
Gifu University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pancreatic cancer is one of most aggressive forms of cancer. After clinical detection it exhibits fast metastatic growth. Heat shock protein 27 (HSP27; HSPB1) has been characterized as a molecular chaperone which modifies the structures and functions of other proteins in cells when they are exposed to various stresses, such as chemotherapy. While the administration of gemcitabine, an anti-tumor drug, has been the standard treatment for patients with advanced pancreatic cancer, accumulating evidence shows that HSP27 plays a key role in the chemosensitivity to gemcitabine. In addition, phosphorylated HSP27 induced by gemcitabine has been associated with the inhibition of pancreatic cancer cell growth. In this review, we summarize the role of phosphorylated HSP27, as well as HSP27, in the regulation of chemosensitivity in pancreatic cancer.

Indexed as

Gene Expression Regulation, NeoplasticAntimetabolites, AntineoplasticBiomarkers, TumorCell Line, TumorDeoxycytidineDrug Resistance, NeoplasmGemcitabineHeat-Shock ProteinsHSP27 Heat-Shock ProteinsHumansIntracellular Signaling Peptides and ProteinsMAP-Kinase-Activated Kinase 2Molecular Chaperonesp38 Mitogen-Activated Protein KinasesPancreatic NeoplasmsPhosphorylationAntimetabolites, AntineoplasticBiomarkers, TumorDeoxycytidineGemcitabineHeat-Shock ProteinsHSP27 Heat-Shock ProteinsHSPB1 protein, humanIntracellular Signaling Peptides and ProteinsMAP-Kinase-Activated Kinase 2Molecular Chaperonesp38 Mitogen-Activated Protein KinasesProtein Serine-Threonine KinaseschemosensitivityHSP27pancreatic cancerphosphorylated HSP27prognosis

Identifiers

PMID26805817
PMCPMC4730376
OpenAlexW2264995374

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.